Interview Dr. Sznol, Annual Meeting 2014 - 100285

Spotlight
Video

Interview Dr. Sznol, Annual Meeting 2014

feeds has 409 videos Subscribe Here

Loading........
Description: Dr. Mario Sznol discusses the results of an expanded phase I study combining ipilimumab and nivolumab in patients with advanced melanoma. The combination immunotherapy resulted in an unprecedented median overall survival of roughly three and a half years (40 months).
Shared By : feeds
Posted on : 06/02/14
Added : 4 years ago
Category : Business Management



Recommended

Nothing found.

More From feeds

Nothing found.